Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of CF Exacerbation in Childhood (PREVEC): Early Recognition of Inflammation by Non-invasive Biomarkers in Exhaled Breath (Condensate)

NCT01241890 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT01241890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01241890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of CF Exacerbation in Childhood (PREVEC): Early Recognition of Inflammation by Non-invasive Biomarkers in Exhaled Breath (Condensate)
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
July 31, 2014
Enrollment
49 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

children, cystic fibrosis, exhaled breath condensate, home monitoring, non-invasive inflammatory markers, quality of life, volatile organic compounds